Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01837862
Title A Phase I/II Study of Mebendazole for the Treatment of Pediatric Gliomas
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mark Atlas
Indications

fibrillary astrocytoma

pleomorphic xanthoastrocytoma

pilocytic astrocytoma

brain glioblastoma multiforme

spinal cord glioma

gliosarcoma

pilomyxoid astrocytoma

glioblastoma

Therapies

Carboplatin + Mebendazole + Temozolomide + Vincristine Sulfate

Bevacizumab + Irinotecan + Mebendazole

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.